Bonus BioGroup Ltd. (BONS.TA)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Joseph Rauch M.B.A. | Executive Chairman of the Board | 410k | -- | 1957 |
| Dr. Shai Meretzki Ph.D. | Founder, CEO, President & Director | 543k | -- | 1969 |
| Ms. Meital Enbar | Chief Financial Officer | 110k | -- | 1979 |
| Dr. Dror Ben David Ph.D. | Chief Operations Officer | 162k | -- | 1977 |
| Dr. Tomer Bronshtein Ph.D. | VP of Innovation & Corporate Development | -- | -- | -- |
| Dr. Vered Kivity M.B.A., Ph.D. | Head of Regulatory Affairs & VP of Clinical Affairs | -- | -- | -- |
Bonus BioGroup Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 49
Description
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial. Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue damage; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is based in Haifa, Israel.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available